Proactive Disclosure

Disclosure of Travel and Hospitality Expenses

Dr. Brien Benoit, Chairperson and CEO

Travel Expenses - September 2, 2006 to December 1, 2006

Date(s)	Purpose	Total Cost
9/20/2006 to 9/20/2006	Pre-Hearing Conference in the matter of Teva Neuroscience G.P-S.E.N.C. and the medicine Copaxone	$15.37
9/27/2006 to 9/27/2006	Board Meeting	$15.37
9/28/2006 to 9/28/2006	Hearing in the matter of Janssen-Ortho Inc. and the medicine Risperdal Consta	$15.37
10/11/2006 to 10/11/2006	Review and signature of documents	$15.37
10/25/2006 to 10/25/2006	Executive Committee Meeting	$15.37
11/1/2006 to 11/1/2006	Heads of Agencies Meeting	$37.00
11/7/2006 to 11/8/2006	Consultations on the Board's Excessive Price Guidelines	$361.94
11/22/2006 to 11/22/2006	Executive Committee Meeting	$15.37
11/27/2006 to 11/29/2006	Hearing in the matter of Janssen-Ortho Inc. and the medicine Risperdal Consta	$46.11
	Total:	$537.27

Hospitality Expenses - September 2, 2006 to December 1, 2006

There are no hospitality expenses for this period.